0001346302-11-000005.txt : 20110719 0001346302-11-000005.hdr.sgml : 20110719 20110718174548 ACCESSION NUMBER: 0001346302-11-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110719 DATE AS OF CHANGE: 20110718 EFFECTIVENESS DATE: 20110719 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001346302 IRS NUMBER: 203352427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-163075 FILM NUMBER: 11973452 BUSINESS ADDRESS: STREET 1: 3925 WEST BRAKER LANE STREET 2: THIRD FLOOR CITY: AUSTIN STATE: TX ZIP: 78759 BUSINESS PHONE: 512-534-8340 MAIL ADDRESS: STREET 1: 3925 WEST BRAKER LANE STREET 2: THIRD FLOOR CITY: AUSTIN STATE: TX ZIP: 78759 D 1 primary_doc.xml X0704 D LIVE 0001346302 XERIS PHARMACEUTICALS INC 3925 WEST BRAKER LANE THIRD FLOOR AUSTIN TX TEXAS 78759 512-534-8340 DELAWARE None None Corporation true Yash Sabharwal 3925 West Braker Lane Third Floor Austin TX TEXAS 78759 Executive Officer John Kinzel 3925 West Braker Lane Third Floor Austin TX TEXAS 78759 Executive Officer Director Mark Saliman 3925 West Braker Lane Third Floor Austin TX TEXAS 78759 Executive Officer Doug Baum 3925 West Braker Lane Third Floor Austin TX TEXAS 78759 Director Other Decline to Disclose 06 false 2011-07-05 false true true true false 0 1958748 1298748 660000 Series A Preferred Stock Financing and Issuance of Series A Preferred Stock Warrants exercisable at $1.02 per share. false 17 0 0 0 false XERIS PHARMACEUTICALS INC /s/ Yash Sabharwal Yash Sabharwal Chief Operating Officer 2011-07-18